Sign inGet started

Abdollahian Neil

Insider CIK 1678223 · CDTX Chief Business Officer · BOLD Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BOLD Boundless Bio, Inc. A Award deriv2024-08-192024-08-2082,051— $082,051SEC↗
BOLD Boundless Bio, Inc. A Award deriv2024-08-192024-08-2023,191— $023,191SEC↗
BOLD Boundless Bio, Inc. A Award deriv2024-08-192024-08-2036,852— $036,852SEC↗
BOLD Boundless Bio, Inc. A Award deriv2024-08-192024-08-2054,871— $054,871SEC↗
BOLD Boundless Bio, Inc. A Award deriv2024-08-192024-08-2019,948— $019,948SEC↗
BOLD Boundless Bio, Inc. D To issuer deriv2024-08-192024-08-2082,051— $00SEC↗
BOLD Boundless Bio, Inc. D To issuer deriv2024-08-192024-08-2023,191— $00SEC↗
BOLD Boundless Bio, Inc. D To issuer deriv2024-08-192024-08-2036,852— $00SEC↗
BOLD Boundless Bio, Inc. D To issuer deriv2024-08-192024-08-2054,871— $00SEC↗
BOLD Boundless Bio, Inc. D To issuer deriv2024-08-192024-08-2019,948— $00SEC↗
BOLD Boundless Bio, Inc. A Award deriv2024-03-272024-03-2923,191— $023,191SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2021-04-012021-04-051,469$2.66 $3.9K57,471SEC↗
CDTX Cidara Therapeutics, Inc. A Award2021-03-312021-04-053,500— $058,940SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2021-03-172021-03-19150,000— $0150,000SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2021-01-052021-04-052,868$2.06 $5.9K55,440SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2020-03-192020-03-23115,000— $0115,000SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2020-01-032020-06-25940$3.42 $3.2K50,308SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2020-01-032020-01-062,340$3.42 $8.0K51,248SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2019-12-182019-12-20100,000— $00SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-12-182019-12-203,704— $03,704SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-12-182019-12-2029,629— $029,629SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2019-12-182019-12-2050,000— $00SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-12-182019-12-209,721— $09,721SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-12-182019-12-2056,945— $056,945SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2019-10-012019-10-037,284$1.98 $14.4K49,588SEC↗
CDTX Cidara Therapeutics, Inc. M Exercise deriv2019-09-122019-09-1617,500— $07,500SEC↗
CDTX Cidara Therapeutics, Inc. M Exercise deriv2019-09-122019-09-164,900— $09,100SEC↗
CDTX Cidara Therapeutics, Inc. A Award2019-09-122019-09-164,900— $056,872SEC↗
CDTX Cidara Therapeutics, Inc. A Award2019-09-122019-09-1617,500— $051,972SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-03-212019-03-2277,000— $077,000SEC↗
CDTX Cidara Therapeutics, Inc. S Sale2019-03-082019-03-082,300$2.44 $5.6K30,472SEC↗
CDTX Cidara Therapeutics, Inc. M Exercise deriv2019-01-312019-02-0114,000— $014,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award2019-01-312019-02-016,000— $032,772SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2018-03-292018-04-0270,000— $070,000SEC↗
CDTX Cidara Therapeutics, Inc. M Exercise deriv2017-09-182017-09-1925,000— $025,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award2017-09-182017-09-1915,000— $020,421SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2017-03-312017-04-0450,000— $050,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2016-07-012016-07-05100,000— $0100,000SEC↗